Multi-center, Investigator Initiated Phase 1 Study of MAGE-A4 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs TBI 1201 (Primary) ; Cyclophosphamide; Fludarabine
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Takara Bio
- 31 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.
- 24 Mar 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov.
- 15 May 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.